| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Mottiwala Aziz serves as a Chief Commercial Officer at TARS. Across recent SEC filings that breaks down to 0 buys and 25 sells. Those positions are worth an estimated $4.1M at current prices.
Historically, Mottiwala Aziz's trades have earned a middling insider score of 51/100 across 21 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -42.1%.
The biggest single holding is TARS (~$4.1M) as Chief Commercial Officer. The recent filings there lean toward selling, a net 72,591 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 13,056 | $68.36 | $892,528.42 | -17.5% | -6.3% | - | |
| Jun 9, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sell10b5-1 | 17,500 | $43.76 | $765,800.00 | -26.9% | +32.0% | - | |
| Mar 20, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 10,565 | $47.88 | $505,856.42 | -14.0% | -17.7% | +29.3% | |
| Mar 18, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 4,766 | $30.60 | $145,839.60 | -8.1% | -5.8% | +50.8% | |
| Jul 19, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sell10b5-1 | 2,400 | $20.05 | $48,120.00 | -5.0% | -33.3% | +35.5% | |
| Jun 8, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sell10b5-1 | 100 | $20.00 | $2,000.00 | -0.2% | -17.7% | +64.0% | |
| Jun 7, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sell10b5-1 | 4,643 | $19.00 | $88,231.23 | -8.8% | -13.0% | +69.0% | |
| Mar 23, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 1,078 | $12.55 | $13,530.89 | -2.0% | +51.2% | +176.9% | |
| Mar 20, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 697 | $12.94 | $9,016.30 | -1.3% | +46.1% | +141.5% | |
| Mar 16, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 336 | $13.43 | $4,512.48 | -0.6% | +38.5% | +135.3% |